Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

被引：0
|
作者：
F. K. Knop
T. Vilsbøll
S. Madsbad
J. J. Holst
T. Krarup
机构：
[1] Gentofte Hospital,Department of Internal Medicine F
[2] University of Copenhagen,Department of Endocrinology
[3] Hvidovre Hospital,Department of Medical Physiology
[4] University of Copenhagen,undefined
[5] The Panum Institute,undefined
[6] University of Copenhagen,undefined
来源：
Diabetologia | 2007年 / 50卷
关键词：
Glucagon; Glucagon-like peptide-1; Glucose-dependent insulinotropic polypeptide; Incretin effect; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：797 / 805
页数：8
相关论文
共 22 条
  • [1] Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
    Knop, F. K.
    Vilsboll, T.
    Madsbad, S.
    Holst, J. J.
    Krarup, T.
    [J]. DIABETOLOGIA, 2007, 50 (04) : 797 - 805
  • [2] Lack of suppression of glucagon during OGTT contributes to the reduced incretin effect in type 2 diabetes
    Knop, F. K.
    Vilsboll, T.
    Madsbad, S.
    Holst, J. J.
    Krarup, T.
    [J]. DIABETOLOGIA, 2006, 49 : 403 - 403
  • [3] Larger glucagon response to OGTT compared to isoglycaemic i.v. glucose infusion translates into increased endogenous glucose production in patients with type 2 diabetes
    Bagger, J. I.
    Lund, A.
    Christensen, M.
    Van Hall, G.
    Holst, J. J.
    Vilsboll, T.
    Knop, F. K.
    [J]. DIABETOLOGIA, 2015, 58 : S281 - S281
  • [4] Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic i.v. glucose infusions in patients with type 2 diabetes and healthy subjects
    Knop, F. K.
    Bagger, J. O.
    Lund, A.
    Vestergaard, H.
    Holst, J. J.
    Vilsboll, T.
    [J]. DIABETOLOGIA, 2009, 52 : S106 - S107
  • [5] Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
    Fotheringham, Amelia K.
    Bagger, Jonatan, I
    Borg, Danielle J.
    McCarthy, Domenica A.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    Forbes, Josephine M.
    [J]. NUTRIENTS, 2020, 12 (10) : 1 - 12
  • [6] The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes
    Luzio, S. D.
    Dunseath, G.
    Lockett, A.
    Broke-Smith, T. P.
    New, R. R.
    Owens, D. R.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (01): : 82 - 87
  • [7] The initial rise in GIP secretion during OGTT correlates with the initial suppression of glucagon secretion in adolescents with obesity and type 2 diabetes
    Kristinsson, H.
    Manell, H.
    Dahlbom, M.
    Presto, J.
    Garedal, C.
    Ritzen, H.
    Vilhelmsson, M.
    Kilstedt, E.
    Johnson, F.
    Stenberg, H.
    Forslund, A.
    Bergsten, P.
    [J]. DIABETOLOGIA, 2018, 61 : S247 - S247
  • [8] INCRETIN SENSITIVITY AND RESPONSE DURING ORAL GLUCOSE TOLERANCE TEST IN TYPE 2 DIABETES ASSESSED BY MATHEMATICAL MODELING OF THE INCRETIN EFFECT
    Tura, A.
    Bagger, J. I.
    Ferrannini, E.
    Holst, J. J.
    Knop, F. K.
    Vilsboll, T.
    Mari, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A99 - A99
  • [9] Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
    Yeow, Toh Peng
    Pacini, Giovanni
    Tura, Andrea
    Hor, Chee Peng
    Lim, Shueh Lin
    Tan, Florence Hui Sieng
    Tong, Chin Voon
    Hong, Janet Yeow Hua
    Zain, Fuziah Md
    Holst, Jens Juul
    Mohamud, Wan Nazaimoon Wan
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [10] Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus
    Chaillous, L
    Rohmer, V
    Maugendre, D
    Lecomte, P
    Marechaud, R
    Marre, M
    Guilhem, I
    Charbonnel, B
    Sai, P
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (03): : 306 - 314
123